Sex differences in intraorgan fat levels and hepatic lipid metabolism: implications for cardiovascular health and remission of type 2 diabetes after dietary weight loss
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Aims/hypothesis: Type 2 diabetes confers a greater relative increase in CVD risk in women compared with men. We examined sex differences in intraorgan fat and hepatic VLDL1-triacylglycerol (VLDL1-TG) export before and after major dietary weight loss. Methods: A group with type 2 diabetes (n = 64, 30 male/34 female) and a group of healthy individuals (n = 25, 13 male/12 female) were studied. Intraorgan and visceral fat were quantified by magnetic resonance and VLDL1-TG export by intralipid infusion techniques. Results: Triacylglycerol content of the liver and pancreas was elevated in people with diabetes with no sex differences (liver 16.4% [9.3–25.0%] in women vs 11.9% [7.0–23.1%] in men, p = 0.57, and pancreas 8.3 ± 0.5% vs 8.5 ± 0.4%, p = 0.83, respectively). In the absence of diabetes, fat levels in both organs were lower in women than men (1.0% [0.9–1.7%] vs 4.5% [1.9–8.0%], p = 0.005, and 4.7 ± 0.4% vs 7.6 ± 0.5%, p< 0.0001, respectively). Women with diabetes had higher hepatic VLDL1-TG production rate and plasma VLDL1-TG than healthy women (559.3 ± 32.9 vs 403.2 ± 45.7 mg kg−1 day−1, p = 0.01, and 0.45 [0.26–0.77] vs 0.25 [0.13–0.33] mmol/l, p = 0.02), whereas there were no differences in men (548.8 ± 39.8 vs 506.7 ± 29.2 mg kg−1 day−1, p = 0.34, and 0.72 [0.53–1.15] vs 0.50 [0.32–0.68] mmol/l, p = 0.26). Weight loss decreased intraorgan fat and VLDL1-TG production rates regardless of sex, and these changes were accompanied by similar rates of diabetes remission (65.4% vs 71.0%) and CVD risk reduction (59.8% vs 41.5%) in women and men, respectively. Conclusions/interpretation: In type 2 diabetes, women have liver and pancreas fat levels as high as those of men, associated with raised hepatic VLDL1-TG production rates. Dynamics of triacylglycerol turnover differ between sexes in type 2 diabetes and following weight loss. These changes may contribute to the disproportionately raised cardiovascular risk of women with diabetes. Graphical abstract:
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“was consolidated by mechanistic studies from a DiRECT subset. 7-9”
From 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sex differences in metabolic regulation and diabetes susceptibility
Tramunt, B., Smati, S., Grandgeorge, N., Lenfant, F., Arnal, J.-F., Montagner, A., & Gourdy, P. (2020) · Diabetologia · doi:10.1007/s00125-019-05040-3 · Cited by 923
Estimated lean body mass as an index for normalization of body fluid volumes in humans
Boer, P. (1984) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1984.247.4.f632 · Cited by 280
Hepatic Lipoprotein Export and Remission of Human Type 2 Diabetes after Weight Loss
Al-Mrabeh, A., Zhyzhneuskaya, S. V., Peters, C., Barnes, A. C., Melhem, S., Jesuthasan, A., Aribisala, B., Hollingsworth, K. G., Lietz, G., Mathers, J. C., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.018 · Cited by 162
Self-citationPramfalk, C., Pavlides, M., Banerjee, R., McNeil, C. A., Neubauer, S., Karpe, F., & Hodson, L. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2649 · Cited by 138
Effect of sex and obesity on basal VLDL-triacylglycerol kinetics
Mittendorfer, B., Patterson, B. W., & Klein, S. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.3.573 · Cited by 132
Wright, A. K., Welsh, P., Gill, J. M. R., Kontopantelis, E., Emsley, R., Buchan, I., Ashcroft, D. M., Rutter, M. K., & Sattar, N. (2020) · Diabetologia · doi:10.1007/s00125-020-05169-6 · Cited by 124
Self-citationWomen Produce Fewer but Triglyceride-Richer Very Low-Density Lipoproteins than Men
Magkos, F., Patterson, B. W., Mohammed, B. S., Klein, S., & Mittendorfer, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2215 · Cited by 124
Al-Mrabeh, A., Hollingsworth, K. G., Shaw, J. A. M., McConnachie, A., Sattar, N., Lean, M. E. J., & Taylor, R. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30303-x · Cited by 122
Self-citationJi, Y., Yiorkas, A. M., Frau, F., Mook-Kanamori, D., Staiger, H., Thomas, E. L., Atabaki-Pasdar, N., Campbell, A., Tyrrell, J., Jones, S. E., et al. (2019) · Diabetes · doi:10.2337/db18-0708 · Cited by 99
Quantification of intrapancreatic fat in type 2 diabetes by MRI
Al-Mrabeh, A., Hollingsworth, K. G., Steven, S., Tiniakos, D., & Taylor, R. (2017) · PLOS ONE · doi:10.1371/journal.pone.0174660 · Cited by 93
Self-citation
Cited by
Sex differences in type 2 diabetes
Kautzky-Willer, A., Leutner, M., & Harreiter, J. (2023) · Diabetologia · doi:10.1007/s00125-023-05891-x · Cited by 624
Cardiovascular risk in diabetes mellitus: Epidemiology, assessment and prevention
Wong, N. D., & Sattar, N. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00877-z · Cited by 495
Self-citationLean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Kelly, T., Irvine, K., Peters, C., Zhyzhneuskaya, S., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00385-6 · Cited by 186
Self-citationThe Role of Beta Cell Recovery in Type 2 Diabetes Remission
Suleiman, M., Marselli, L., Cnop, M., Eizirik, D. L., Luca, C. D., Femia, F. R., Tesi, M., Guerra, S. D., & Marchetti, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137435 · Cited by 49
“Sex does not seem to affect changes in intrapancreatic fat and VLDL1-triglyceride production after weight loss [46].”
BackgroundZhu, R., Craciun, I., Bernhards-Werge, J., Jalo, E., Poppitt, S. D., Silvestre, M. P., Huttunen‐Lenz, M., McNarry, M. A., Stratton, G., Handjiev, S., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05716-3 · Cited by 43
“Our findings on sex differences in weight loss are in line with a meta-analysis of six lifestyle-based weight loss RCTs [14] and a recent study on sex differences in intraorgan fat levels and hepatic lipid metabolism [16].”
BackgroundResultGlobal risk factors, epidemiology, and disease burden of type 2 diabetes
Chen, K., Zhang, H., Wu, N., Li, B., Li, S., & Mu, Y. (2025) · Science China Life Sciences · doi:10.1007/s11427-024-3036-4 · Cited by 42
“In type 2 diabetes, women ’ s liver and pancreatic fat content are comparable with men ’ s and are associated with increased very low-density lipoprotein triglyceride production in the liver (Jesuthasan et al., 2022).”
Zhang, Y., Liu, Y., & Petrov, M. S. (2025) · Obesity Reviews · doi:10.1111/obr.13914 · Cited by 26
Re-evaluating the concept of remission in type 2 diabetes: a call for patient-centric approaches
Khunti, K., Papamargaritis, D., Aroda, V. R., Anjana, R. M., & Kashyap, S. R. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00134-2 · Cited by 22
Janssen, J. A. M. J. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189191 · Cited by 20
“The >10 kg weight loss was associated with durable recovery of beta cell function and normalization of glucose level in the majority [148,152,153].”
Dyson, N. J., Kattner, N., Al-Selwi, Y., Honkanen‐Scott, M., Shaw, M. F., Brack, C. A., Coulthard, R., Flaxman, C. S., Richardson, S. J., & Shaw, J. (2025) · Diabetologia · doi:10.1007/s00125-025-06547-8 · Cited by 21
Skudder‐Hill, L., Sequeira, I. R., Ko, J., Poppitt, S. D., & Petrov, M. S. (2024) · Obesity · doi:10.1002/oby.24154 · Cited by 15
Remission of type 2 diabetes: A critical appraisal
Ricci, M., Mancebo-Sevilla, J. J., Cobos-Palacios, L., Sanz‐Cánovas, J., Sampalo, A. L., Hernández-Negrín, H., Velasco, M. Á. P., Perez-Belmonte, L. M., Bernal-López, M. R., & Gómez‐Huelgas, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1125961 · Cited by 15
“A retrospective analysis of patients included in the DiRECT study has shown a decrease in risk score after the intervention, but no direct evidence of a decrease in mortality and cardiovascular events is available (38).”
BackgroundConceptual framework and expert guidance on intrapancreatic fat deposition: the Melbourne consensus
Petrov, M. S., Yamazaki, H., Lu, G., Al-Mrabeh, A. H., Luchini, C., Dong, X., Hamada, T., Liu, Y., Oyama, H., Rospleszcz, S., et al. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01224-6 · Cited by 14
Self-citationSluková, D., Deischinger, C., Just, I., Kaufmann, U., Trattnig, S., Krššák, M., Kosi‐Trebotic, L., Harreiter, J., & Kautzky‐Willer, A. (2024) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2024.100379 · Cited by 10
Soldevila‐Domenech, N., Pastor, A., Sala‐Vila, A., Lázaro, I., Boronat, A., Muñoz, D., Castañer, O., Fagundo, A. B., Corella, D., Fernández‐Aranda, F., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1076677 · Cited by 12
Mukherjee, M., Mukherjee, S., Thokala, H. R., & Ali, R. H. (2025) · PLoS ONE · doi:10.1371/journal.pone.0335676 · Cited by 9
“It is in concordance with studies describing the cardiometabolic changes in women increasing the risk of cardiometabolic multimorbidity [39,40,41] correlating menopause with the onset of low mood or mental health challenges amongst women [42].”
MASLD, diabetes and PMOS across the female life stages
Stener‐Victorin, E., Carlsson, S., Hagström, H., & Taebnia, N. (2026) · Diabetologia · doi:10.1007/s00125-026-06761-y · Cited by 7
“MASLD is generally more prevalent in men [3]; however, this sex difference disappears in individuals with type 2 diabetes, suggesting loss of the typical female protection against hepatic steatosis [8, 9].”
Li, S., Yang, B., Shang, S., & Jiang, W. (2025) · Obesity · doi:10.1002/oby.24338 · Cited by 7
“Hormonal changes after menopause lead to a redistribution of body fat from a gynoid (lower body) to an android (central) pattern, which is associated with increased insulin resistance, dyslipidemia, and elevated blood pressure [35].”
Dysglycemia in young women attenuates the protective effect against fatty liver disease
de, A. P.-M., Julián, M. T., Pera, G., Caballería, L., Morillas, R. M., Torán‐Monserrat, P., Expósito, C., Franch‐Nadal, J., Mauricio, D., & Alonso, N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.971864 · Cited by 6
Korn, A., Nadeem, C., Bos, E. N., Niessen, H. W. M., Şimşek, S., & Krijnen, P. A. J. (2023) · Pathobiology · doi:10.1159/000531542 · Cited by 4
“Moreover, in non-diabetic participants both hep-atic fat levels and plasma liver-derived triacylglycerol levels were lower in women than in men [27].”
BackgroundHarreiter, J., Just, I., Weber, M., Klepochová, R., Bastian, M., Winhofer, Y., Wolf, P. S., Scherer, T., Leutner, M., Kosi‐Trebotic, L., et al. (2024) · Obesity · doi:10.1002/oby.24153 · Cited by 4
“Interestingly, this difference disap-pears between male and female individuals with worsening glucose metabolism, which is indicative of faster increases of HCL in female individuals progressing to T2DM [5,40].”
InfluentialVery low calorie diets and total diet replacement in type 2 diabetes: where are we now?
Taylor, R. (2024) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2022.000055 · Cited by 4
Self-citationMai, Y. (2023) · Diabetologia · doi:10.1007/s00125-023-05919-2 · Cited by 2
“A recent study by Jesuthasan et al [5] reported * Yanpei Mai mcmaiyanpei@mail.”
BackgroundResultType 2 diabetes: the problem and the solution
Taylor, R. (2022) · British Journal of Diabetes · doi:10.15277/bjd.2022.366 · Cited by 1
Self-citationGeschlechtsabhängige Unterschiede im Lipidstoffwechsel und beim kardiovaskulären Risiko
Krome, S. (2022) · Diabetologie und Stoffwechsel · doi:10.1055/a-1732-8810
Marcos, P. J. T., López‐González, Á. A., Rifá, E. M.-A., Paublini, H., Sánchez, C. M., López, P. J. T., & Ramírez‐Manent, J. I. (2025) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2025.102514
Type 2 diabetes, sex and metabolic dysfunction-associated steatotic liver disease
Lonardo, A., Jamalinia, M., & Weiskirchen, R. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i5.119756
The regulation of intrahepatic fatty acid partitioning within the human liver: the effect of sex
Dennis, K. M. J. H., Start, C. A. T., Josh, D., & Hodson, L. (2026) · Clinical Science · doi:10.1042/cs20260180 · Cited by 1
“…differences have been observed in hepatic FA handling, including differences in FA uptake, DNL, mitochondrial β -oxidation, and VLDL secretion [3,13–15] and it has been suggested that sex-dependent differences contribute to sex-based disparities in IHTG content and cardiometabolic risk [16,17].”
Metadata
- Authors
- Jesuthasan, A., Zhyzhneuskaya, S., Peters, C., Barnes, A. C., Hollingsworth, K. G., Sattar, N., Lean, M. E. J., Taylor, R., & Al-Mrabeh, A. H.
- Affiliations
- Newcastle University (GB)
- University of Glasgow (GB)
- The Queen's Medical Research Institute (GB)
- Corresponding author
- Taylor, Roy
- Al-Mrabeh, Ahmad H.
- ORCID
- Venue
- Diabetologia
- Published
- 2021-10-16
- Volume
- 65
- Issue
- 1
- Pages
- 226-233
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC8660759
- OpenAlex
- W3207018977
- Cited by
- 30
- References
- 15
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 6 · 2023: 5 · 2022: 6
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Diabetologia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Diabetes UK (13/0004691)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- type 2 diabetes, sex differences, hepatic lipid metabolism, hepatic triglycerides, visceral fat, dietary weight loss, cardiovascular risk, hepatic steatosis, women's health, Intralipid infusion, magnetic resonance
- MeSH terms
- Diabetes Mellitus, Type 2, Female, Humans, Lipoproteins, VLDL, Liver, Male, Sex Characteristics, Triglycerides, Weight Loss, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.